Canopy Growth (CGC) EBIT Margin (2019 - 2025)
Canopy Growth's (CGC) quarterly EBIT Margin came in at 29.15% in Q4 2025, down 153.0% year-on-year from 55.0% in Q4 2024, and down 43.22% quarter-over-quarter from 20.35% in Q3 2025.
Canopy Growth (CGC) EBIT Margin (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed EBIT Margin across 7 years of filings, most recently posting 29.15% for Q4 2025.
- EBIT Margin for Q4 2025 came in at 29.15%, down 153.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 38.37% (up 2162.0% YoY), and the FY2025 annual result was 50.39%, up 1611.0% from the prior year.
- EBIT Margin came in at 29.15% for Q4 2025 at Canopy Growth, down from 20.35% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 373.57% in Q1 2022 to a low of 1765.54% in Q1 2023.
- The 5-year median for EBIT Margin is 74.51% (2025), against an average of 222.85%.
- Peak annual rise in EBIT Margin reached 167779 bps in 2023, while the deepest fall reached 213912 bps in 2023.
- Canopy Growth's EBIT Margin stood at 96.73% in 2021, then retreated by 20 bps to 116.19% in 2022, then surged by 42 bps to 66.97% in 2023, then surged by 59 bps to 27.62% in 2024, then decreased by 6 bps to 29.15% in 2025.
- The last three EBIT Margin figures came in at 29.15% (Q4 2025), 20.35% (Q3 2025), and 31.36% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -29.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.15% |
| Sep 30, 2025 | -20.35% |
| Jun 30, 2025 | -31.36% |
| Mar 31, 2025 | -76.08% |
| Dec 31, 2024 | -27.62% |
| Sep 30, 2024 | -72.94% |
| Jun 30, 2024 | -38.41% |
| Mar 31, 2024 | -89.26% |
| Dec 31, 2023 | -66.97% |
| Sep 30, 2023 | -8.54% |
| Jun 30, 2023 | -61.65% |
| Mar 31, 2023 | -1,765.54% |
| Dec 31, 2022 | -116.19% |
| Sep 30, 2022 | -148.52% |
| Jun 30, 2022 | -1,739.45% |
| Mar 31, 2022 | 373.57% |
| Dec 31, 2021 | -96.73% |
| Sep 30, 2021 | -163.93% |
| Jun 30, 2021 | -120.77% |
| Mar 31, 2021 | -157.10% |